You are here: Home » News-CM » Companies » News
Business Standard

Zydus receives final approval for Clozapine Tablets

Capital Market 

From USFDA

Zydus Pharmaceuticals Inc, a wholly owned subsidiary of Cadila Healthcare has received the final approval from the USFDA to market Clozapine Tablets in strengths of 25 mg, 50 mg, 100 mg and 200 mg. Thr drug is used to treat schizophrenia. It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, December 08 2017. 11:09 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU